Related Experiment Video
Updated: Feb 24, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Cerebral venous sinus thrombosis in homocystinuria: Dietary intervention in conjunction with anticoagulation
Sufin Yap1, Deborah Annesley-Williams2,3, Orla Hardiman4,5
1Department of Inherited Metabolic Diseases, Sheffield Children's NHS Foundation Trust, Sheffield, UK.
Insights
Cerebral venous sinus thrombosis (CVST) can present acutely or chronically. Early anticoagulation and dietary changes in a homocystinuria patient led to a favorable outcome in this case.
Area of Science:
- Neurology
- Vascular Medicine
- Genetics
Background:
- Cerebral venous sinus thrombosis (CVST) presents variably, posing diagnostic challenges.
- CVST is an uncommon complication of homocystinuria, a metabolic disorder.
Observation:
- A case of CVST in a patient with homocystinuria is presented.
- The patient experienced both acute and chronic symptoms.
Findings:
- Early anticoagulation therapy was initiated.
- Dietary intervention was implemented concurrently.
- These interventions were associated with a positive clinical outcome.
Implications:
- Highlights the importance of considering CVST in homocystinuria.
- Suggests that prompt anticoagulation and dietary management can improve prognosis.
- Emphasizes the need for early diagnosis and intervention in complex cases.
Abstract:
The presentation of cerebral venous sinus thrombosis may be acute or chronic with a progressive clinical course. The diagnosis can be challenging, and there are several clinical syndromes associated with the disease. It is also an uncommon but recognised complication of homocystinuria. We describe a case where early anticoagulation, together with dietary intervention, was associated with a favourable clinical outcome.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
